An increase in the risk of developing uterine serous carcinoma (USC) has been observed among BRCA1 and BRCA2 germline pathogenic variant carriers in the published literature. However. routine germline genetic testing is not currently incorporated into USC management guidelines. The primary objective of this study is to define the incidence of germline pathogenic variants identified th... https://www.spidertattooz.com/The-GelBottle-Inc-Gel-Polish-Audrey-67oz-p17921/